Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Novelos Therapeutics
Novelos Therapeutics Closes $5.4 Million Public Offering
Novelos Therapeutics Closes $5.4 Million Public Offering
Yahoo
Novelos Therapeutics
stock offering
News
The Top 10 Phase III Failures of 2010
Fierce Biotech
Antisoma
ASA404
AstraZeneca
clinical trials
diabetes
dimebon
Eli Lilly
Ipsen
Medivation
Merck
Novartis
Novelos Therapeutics
ocrelizumab
Pfizer
Recentin
rheumatoid arthritis
Roche
Sanofi
semagacestat
taspoglutide
Vical
vicriviroc
zibotentan
»
3 comments
News
Drug Pipeline Pulse Check: High Expectations for Novartis
Seeking Alpha
Alcon
Genzyme
Novartis
Novelos Therapeutics
»
Login
or
register
to post comments
News
Novelos cancels lung-cancer drug project
Bizjournals.com
lung cancer
Novelos Therapeutics
»
Login
or
register
to post comments
News
Brower Piven Encourages Investors Who Have Losses in Excess of $50,000 From Investment in Novelos Therapeutics, Inc. to Inquire About the Lead Plaintiff Position
MarketWire
lawsuits
Novelos Therapeutics
»
Login
or
register
to post comments
News
For Biotech in 2010, It's Déjà Vu All Over Again
Seeking Alpha
Adventrx
Alkermes
Amag Pharmaceuticals
Amylin
Cell Therapeutics
Delcath
Dendreon
Isis Pharmaceuticals
MannKind
Novelos Therapeutics
XenoPort
»
16 comments
News
The Egleston Law Firm and Rigrodsky & Long, P.A. File Class Action Suit Against Novelos Therapeutics, Inc.
Yahoo/Global NewsWire
lawsuits
Novelos Therapeutics
»
3 comments
News
Biotech Stock Mailbag: BioSante Pharma
TheStreet.com
ARYx
BioSante
Health Discovery
InterMune
Novelos Therapeutics
Proctor & Gamble
Xoma
»
1 comment
News
Novelos Therapeutics Pivotal Phase 3 Lung Cancer Trial Does Not Meet the Primary Survival Endpoint
Marketwatch
lung cancer
Novelos Therapeutics
»
Login
or
register
to post comments
News
10 Biotech Stocks on Clinical Trials Watch
TheStreet.com
Affymax
Allos
Amgen
Delcath
GenVec
Genzyme
Isis Pharmaceuticals
Medivation
Novelos Therapeutics
Optimer
Vertex Pharmaceuticals
»
3 comments
1
2
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT